Therefore, the disulfide bond HMGB1 isoform is a biomarker of inflammation, which indicates that blocking the extracellular disulfide bond HMGB1 isoform may be a potential direction for the treatment of inflammation and immune-related diseases, including stroke. The gene discussed is HMGB1; the disease is stroke disorder.